KURA
Kura Oncology Inc
NASDAQ: KURA · HEALTHCARE · BIOTECHNOLOGY
$8.83
+0.91% today
Updated 2026-04-30
Market cap
$776.67M
P/E ratio
—
P/S ratio
11.51x
EPS (TTM)
$-3.18
Dividend yield
—
52W range
$5 – $12
Volume
1.5M
Kura Oncology Inc (KURA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-31765.00 | $-21366.00 | $-19244.00 | $-19244.00 | $-22678.00 | $-24418.00 | $-2547.00 | $-17.93M | $-25.35M | $-28.44M | $-48.66M | $-54.76M | $-69.83M | $-104.55M | $-110.06M | $-124.82M | $134.32M | $-64.06M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $84.00 | $64000.00 | $0.00 | $2.17M | $2.17M | $2.17M | $2.17M | $1.15M | $626000.00 | $168000.00 | $472000.00 | $6.64M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | $711.00 | $2.26M | $2.09M | $4.54M | $8.65M | $9.41M | $12.81M | $23.58M | $26.32M | $28.08M | $33.90M | $37.11M |
| Free cash flow | $-31765.00 | $-21366.00 | $-19244.00 | $-19244.00 | $-22678.00 | $-24418.00 | $-2631.00 | $-17.99M | $-25.35M | $-30.61M | $-50.83M | $-56.93M | $-72.00M | $-105.70M | $-110.69M | $-124.99M | $133.84M | $-70.70M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $582.00 | $1766.00 | $-955.00 | $14.32M | $-5.72M | $1.71M | $4.69M | $10.02M | $299.57M | $-234.82M | $-38.87M | — | — | — |